NCT04905979Phase 2Completed

Trial of AD113 and Atomoxetine in OSA Patients With Hypertension

Study sponsor: Apnimed

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2023-01-31Actual
Enrollment · participants21Actual
Source updated2023-08-21Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.